Our monthly seminar series is a CME accredited event held on the first Tuesday of each month at 12:45pm.

• Tuesday, November 12, 2019–“EIPM Seminar Series Lecture,” with Laura Santambrogio, M.D., Ph.D., EIPM Associate Director for Precision Immunology
• Wednesday, December 11, 2019–“EIPM Seminar Series Lecture,” with Seth Paul Lerner, M.D., FACS, Professor of Urology, Baylor College of Medicine
• Thursday, December 12, 2019–“EIPM Seminar Series Lecture,” with Yuri E. Nikiforov, M.D., Ph.D. Professor of Pathology, University of Pittsburgh

# # #

---

“Monitoring Clonal Dynamics of Cancer in the Clinic”
Presented by:
Shridar Ganesan, M.D., Ph.D., Chief, Molecular Oncology
Associate Director for Translational Research, Medical Oncologist

Rutgers Cancer Institute of New Jersey

 

 

---

---

February 6, 2018
“Translational Pharmacogenomics: Discovery, Education, and Implementation”
Stuart A. Scott, Ph.D., FACMG
Associate Professor, Department of Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
Division Head, Pharmacogenomics, Director, Cytogenetics and Cytogenomics

 

January 9, 2018
“MSK-IMPACT: Tumor and normal sequencing to guide diagnosis, treatment selection, and clinical trial enrollment”
Michael F. Berger, PhD
Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

 

December 5, 2017
“Tumor Microenvironment Immune Infiltration & Clinical Utility of Targeted Sequencing for Pediatric Brain Tumors”
Prajwal Rajappa, MD
Pediatric Brain Tumor Precision Medicine Fellow
Weill Cornell Brain and Spine Center

 

November 17, 2017 (Special Seminar)
“Empirical Findings on the Path to Genomic Medicine”
Robert C. Green, MD, MPH
Professor of Medicine (Genetics)
Director, Genomes2People Research Program
Brigham and Women’s Hospital | Broad Institute | Harvard Medical School

 

November 7, 2017
“Recent discoveries, therapies, and clinical implementation of rational pediatric oncology at MSKCC,” by Alex Kentsis, MD, PhD
Molecular Pharmacology Program
Experimental Therapeutics Center
Department of Pediatrics, Memorial Sloan Kettering Cancer Center

 

October 3, 2017
“Uveal Melanoma: Case History of a Mutant GPCR,” by Thomas Sakmar, MD
Richard M. & Isabel P. Furlaud Professor
The Rockefeller University

 

 

September 5, 2017
“Computational Pathology to Precision Medicine,” by Jeffrey A. Golden, MD
Chair, Department of Pathology
Brigham & Women’s Hospital

 

 

August 1, 2017
“Innovation through Collaboration: How an Emerging Pediatric Cancer Data Discovery Landscape is Changing the Way We Do Research,” by Adam C. Resnick, PhD
Director of the Center for Data-Driven Discovery in Biomedicine (D3b)
Director for Neurosurgical Translational Research, Division of Neurosurgery
Director of Children’s Brain Tumor Tissue Consortium in Neurosurgery (CBTTC)
The Children’s Hospital of Philadelphia

 

July 11, 2017
“NGS-based Comprehensive Oncogenic Virus Detection & Typing – Pilot Study Results,” by Wendy Yang, MD
Clinical Research Fellow
Department of Pathology
Memorial Sloan Kettering Cancer Center

 

 

June 20, 2017
“Advanced Precision Oncology in Leukemia and Other Hematologic Malignancies,” by Duane Hassane, MD
Assistant Professor of Computational Biomedicine in Medicine
Weill Cornell Medicine

 

May 2, 2017
“Personalizing the Genome: The Platelet αIIbβ3 Story,” by Barry S. Coller, MD
David Rockefeller Professor of Medicine
Head, Allen and Frances Adler Laboratory of Blood and Vascular Biology
Physician-in-Chief, Rockefeller University Hospital
Vice President for Medical Affairs, Rockefeller University

 

January 10, 2017
“Accelerating Precision Cancer Medicine Through Clinical Computational Oncology,” by Eliezer M. Van Allen, MD
Assistant Professor of Medicine, Harvard Medical School
Department of Medical Oncology, Dana-Farber Cancer Institute
Department of Medicine, Brigham and Women’s Hospital
Associate Member, Broad Institute

December 9, 2016 (Special Seminar)
“Healthcare-integrated Biobanking / Pharmacogenomics of Fluoropyrimidines,” by Carlo Largiadèr, PhD
Vice-Director / Head of Liquid Biobank Bern
University Institute of Clinical Chemistry UKC
Inselspital, Bern University Hospital

 

 

December 6, 2016
“Clinical Implications of Long Non-coding RNAs in Solid Tumors,” by Christopher A. Maher, Ph.D.
Assistant Professor, Department of Medicine, Oncology Division, Stem Cell Biology
Department of Biomedical Engineering
Washington University Genome Institute

November 1, 2016
“Clinical impact of next-generation sequencing in pediatric oncology,” by Andrew Kung, MD, PhD
Chairman and Professor, Department of Pediatrics
Memorial Sloan-Kettering Cancer Center

 

 

October 11, 2016
“Metabolomics and Proteomics in Precision Medicine,” by Karsten Suhre, PhD
Professor of Physiology and Biophysics
Director of the Bioinformatics & Virtual Metabolomics Core
Weill Cornell Medicine-Qatar

 

 

September 13, 2016
“Algorithms for characterizing sequenced genomes and quantifying cancer evolution,” by Iman Hajirasouliha, PhD
Assistant Professor, Computational Genomics
Weill Cornell Medicine

 

August 9, 2016
“Emerging Themes in Cancer Biology and Their Potential Diagnostic Implications,” by Zoltan Nagy Oltvai, MD
Associate Professor, Department of Pathology
University of Pittsburgh School of Medicine

 

July 19, 2016
“Technology Development for Innovation in NGS-based Genomic Medicine,” by Jonathan Reichel, PhD
Lead Bioinformatics Scientist
Innovation Laboratory
Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

June 9, 2016
“From Germline and Somatic Genetics to Translational Genomics of Bladder Cancer,” by Ludmila Prokunina-Olsson, PhD
Senior Investigator, Laboratory of Translational Genomics
Division of Cancer Epidemiology and Genetics
National Cancer Institute
National Institutes of Health

 

 

March 1, 2016
“Trials and correlations: Tumor heterogeneity and clinical applications of NGS sequencing,” by Jennifer J.D. Morrissette, PhD, FACMG
Scientific Director, Clinical Cancer Cytogenetics
Department of Pathology, University of Pennsylvania

 

January 5, 2016
“Integration of Genomics into Clinical Care for Precision Medicine,” by Wendy Chung, MD, PhD
Associate Professor, Pediatrics in Medicine
Director, Endocrine Research Center Molecular Genetics Core
Columbia University

 

December 1, 2015
“Towards Precision Medicine in Neurodevelopmental Diseases,” by David Goldstein, PhD
Director, Institute for Genomic Medicine
John E. Borne Professor
Professor of Genetics and Development
Columbia University Medical Center

 

 

November 3, 2015
“Next-­‐gen sequencing approaches for measurement of circulating nucleic acids,” by Aghijit Patel, MD, PhD
Assistant Professor, Therapeutic Radiology
Yale University

 

 

October 6, 2015
“The Million Veteran Program – Past, Present, and Future,” by Ron Przygodzki, MD
Director, Clinical Genetic Medicine Research
U.S. Department of Veterans Affairs

 

June 2, 2015
“Next Generation Sequencing: Precision Cancer Diagnostics and Beyond,” by Marina N. Nikiforova, MD, FCAP
Professor of Pathology
Director, Molecular and Genomic Pathology Laboratory
University of Pittsburgh Medical Center

 

May 5, 2015
“The MSK-IMPACT Program: Prospective Clinical Cancer Genomics to Enable Personalized Oncology and Advance the Clinical Development of Targeted Therapies,” by Mark Landanyi, MD
The William Ruane Chair in Molecular Oncology
Attending Pathologist, Molecular Diagnostics Service
Member, Human Oncology and Pathogenesis Program
Memorial Sloan-Kettering Cancer Center

 

March 10, 2015
“Cancer Predisposition Testing in the Genomic Era,” by Colin Pritchard, MD, PhD
Assistant Professor, Medicine
Associate Director, Genetics and Solid Tumors Laboratory
University of Washington